Skip to main content

Gorospe, Myriam

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #356
  • Sustained Excellence
  • Top 5% Funded
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$8.1M
Full award amounts, FY2023
Award Records
11
Records listing this PI
Award-Linked Rank
#356
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gorospe, Myriam. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Gorospe, Myriam as a PI. Multi-PI records show the full award amount for context.

  • 1ZIAAG000393-16ZIAContact PI
    Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging
    $2.1M
    award amount
  • 1ZIAAG000511-26ZIAContact PI
    Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis
    $1.9M
    award amount
  • 1ZIAAG000394-16ZIAContact PI
    Post-transcriptional regulation of energy usage: glucose and lipid metabolism
    $1.5M
    award amount
  • 1ZIAAG000518-19ZIAContact PI
    RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies
    $961.1K
    award amount
  • 1ZIAAG000492-02ZIAContact PI
    Profiling splicing isoforms in single cells in the atherosclerosis niche
    $606.6K
    award amount
  • 1ZICAG000613-16ZICContact PI
    Bioinformatic Analysis of the Genetics of Common Complex Diseases
    $322.1K
    award amount
  • 1ZIAAG000467-01ZIAContact PI
    A broad catalog of transcriptomic and proteomic markers for human cell senescence
    $214.7K
    award amount
  • 1ZIAAG000483-03ZIAContact PI
    Characterizing Senescent Cell Heterogeneity by Surface Proteins: Single-Cell CITE-Seq
    $155.7K
    award amount
  • 1ZIAAG000475-01ZIAContact PI
    Intracellular vesicle trafficking in senescent cells role of the Golgi complex?
    $107.4K
    award amount
  • 1ZIAAG000474-01ZIAContact PI
    Splice-switching antisense oligonucleotides (SSOs) as a senomorphic intervention
    $107.4K
    award amount

+1 more grant not shown.

Award organization

Organizations that administered FY2023 awards listing Gorospe, Myriam as a PI.

FY2023 award administered by National Institute On Aging ().

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    National Institute On Aging
  2. 2009
    $500K Cumulative Funding
  3. 2009
    $1M Cumulative Funding
  4. 2009
    $2M Cumulative Funding
  5. 2009
    Entered Top 50% Nationally
    Ranked #2819
  6. 2009
    Entered Top 25% Nationally
    Ranked #2819
  7. 2011
    $5M Cumulative Funding
  8. 2012
    Entered Top 10% Nationally
    Ranked #1627
  9. 2013
    $10M Cumulative Funding
  10. 2017
    Entered Top 5% Nationally
    Ranked #617
  11. 2018
    $25M Cumulative Funding
  12. 2022
    $50M Cumulative Funding